Yuki Fujioka

6PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInorganic materials (incl. nanomaterials)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 18, 2026
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.

|Apr 07, 2026
Ponatinib inhibits LCK and PI3K signaling and promotes CD8+ T stem cell memory cell development.

Yuki Okuhiro, Sachiko Ito, Keisuke Watanabe

|Apr 29, 2025
Bosutinib for Successful Treatment-Free Remission in Chronic Myeloid Leukemia.

Yuki Fujioka, Maiko Abumiya, Takaaki Ono

|Jan 09, 2025
Multiple myeloma-associated non-crystalline proximal tubulopathy and crystalline cast nephropathy: Biochemical and structural features of disease-causing monoclonal kappa light chains.

Toshinori Ezawa, Riku Otomo, Yumi Kariya

|May 05, 2023
The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.

Kazuaki Kameda, Ryo Yanagiya, Yuji Miyatake

|Dec 10, 2021
Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia.

Yuki Fujioka, Daisuke Sugiyama, Itaru Matsumura

Pageof 1

Frequent Collaborators

6 joint publications

Naoto Takahashi

2 joint publications

Hiroyoshi Nishikawa

2 joint publications

Hitoshi Kiyoi

1 joint publications

Daisuke Sugiyama